Pfizer Inc. (PFE)

28.45 -0.36 (-1.25%) USD  |  NYSE  |  Sep 04, 16:00
28.42 -0.03 (-0.11%) After-Hours: 20:00
More

Pfizer SG&A Expense (TTM) : 13.72B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 13.72B
March 31, 2026 13.72B
December 31, 2025 13.79B
September 30, 2025 13.91B
June 30, 2025 13.96B
March 31, 2025 14.27B
December 31, 2024 14.73B
September 30, 2024 15.03B
June 30, 2024 15.07B
March 31, 2024 14.85B
December 31, 2023 14.77B
September 30, 2023 14.84B
June 30, 2023 14.95B
March 31, 2023 14.50B
December 31, 2022 13.68B
September 30, 2022 13.14B
June 30, 2022 12.64B
March 31, 2022 12.52B
December 31, 2021 12.70B
September 30, 2021 12.35B
June 30, 2021 12.11B
March 31, 2021 11.85B
December 31, 2020 11.61B
September 30, 2020 12.10B
June 30, 2020 12.70B
Date Value
March 31, 2020 13.55B
December 31, 2019 14.35B
September 30, 2019 14.12B
June 30, 2019 14.35B
March 31, 2019 14.38B
December 31, 2018 14.46B
September 30, 2018 15.00B
June 30, 2018 15.01B
March 31, 2018 14.90B
December 31, 2017 14.79B
September 30, 2017 14.66B
June 30, 2017 14.72B
March 31, 2017 14.76B
December 31, 2016 14.84B
September 30, 2016 15.46B
June 30, 2016 15.17B
March 31, 2016 15.09B
December 31, 2015 14.81B
September 30, 2015 13.74B
June 30, 2015 14.03B
March 31, 2015 14.16B
December 31, 2014 14.10B
September 30, 2014 14.27B
June 30, 2014 14.11B
March 31, 2014 14.18B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Johnson & Johnson 25.14B
Eli Lilly & Co. 12.24B
Merck & Co., Inc. 11.14B
Bristol Myers Squibb Co. 7.413B
Viatris, Inc. 3.981B